MENU

SONN

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Sonnet BioTherapeutics Holdings (SONN) Ownership - Who owns Sonnet BioTherapeutics Holdings?

Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

N/A

Address

100 Overlook Center

Phone

+1 609 375-2227

Employees

12

Web

https://www.sonnetbio.com

Details

Group

Domestic Stock Funds

Category

Biotechnology

Capitalization

8.6M

P/E Ratio

0.29

Total Cash

321.3K

Projected Growth

N/A

Total Debt

68.84K

Revenue

1M

Risk (Beta)

1.22

Dividend Yield

N/A

Total Cash/Share

0.05

Total Debt/Equity

N/A

Revenue/Share

0.37 USD as % of share price

View a ticker or compare two or three

VS

VS

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for SONN

A.I. Advisor

published General Information

General Information

a company, which engages in the development of biologic drugs with enhanced single or bispecific mechanisms

Industry Biotechnology

Profile

Details

Industry

N/A

Address

100 Overlook Center

Phone

+1 609 375-2227

Employees

12

Web

https://www.sonnetbio.com